Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-004081
Filing Date
2025-03-31
Accepted
2025-03-31 08:03:08
Documents
110
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kala-20241231x10k.htm   iXBRL 10-K 3852715
2 EX-4.3 kala-20241231xex4d3.htm EX-4.3 34664
3 EX-19.1 kala-20241231xex19d1.htm EX-19.1 73475
4 EX-21.1 kala-20241231xex21d1.htm EX-21.1 5150
5 EX-23.1 kala-20241231xex23d1.htm EX-23.1 4675
6 EX-31.1 kala-20241231xex31d1.htm EX-31.1 9029
7 EX-31.2 kala-20241231xex31d2.htm EX-31.2 8824
8 EX-32.1 kala-20241231xex32d1.htm EX-32.1 5276
9 EX-32.2 kala-20241231xex32d2.htm EX-32.2 6037
10 GRAPHIC kala-20241231x10k006.jpg GRAPHIC 42707
11 GRAPHIC kala-20241231x10k007.jpg GRAPHIC 65834
12 GRAPHIC kala-20241231x10k008.jpg GRAPHIC 35606
13 GRAPHIC kala-20241231x10k009.jpg GRAPHIC 20097
14 GRAPHIC kala-20241231x10k010.jpg GRAPHIC 45242
15 GRAPHIC kala-20241231x10k011.jpg GRAPHIC 28954
16 GRAPHIC kala-20241231x10k012.jpg GRAPHIC 44551
  Complete submission text file 0001558370-25-004081.txt   13474045

Data Files

Seq Description Document Type Size
17 EX-101.SCH kala-20241231.xsd EX-101.SCH 81646
18 EX-101.CAL kala-20241231_cal.xml EX-101.CAL 70650
19 EX-101.DEF kala-20241231_def.xml EX-101.DEF 439550
20 EX-101.LAB kala-20241231_lab.xml EX-101.LAB 729998
21 EX-101.PRE kala-20241231_pre.xml EX-101.PRE 594377
113 EXTRACTED XBRL INSTANCE DOCUMENT kala-20241231x10k_htm.xml XML 1724563
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38150 | Film No.: 25788994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)